Study of the Safety and Efficacy of Desvenlafaxine Succinate for Vasomotor Symptoms in Postmenopausal Women

Completed · Phase 3

Conditions studied: Menopause, Vasomotor System

In brief

The purpose of this study is to evaluate the efficacy and safety of 100 mg and 150 mg of DVS SR, an extended release form of desvenlafaxine succinate, in comparison to placebo for the treatment of Vasomotor Symptoms (VMS) associated with menopause in a population of postmenopausal women.

Key facts

Study ID

NCT00369434

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

450

Starts

2006-06-01

Expected to finish

2007-02-01

Last updated by the study team

2007-06-01

Who can join

Age: any. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Generally healthy, postmenopausal women who seek treatment for hot flushes
• Body Mass Index (BMI) less than or equal to 40 kg/m2
• Other inclusions apply.

You may not qualify if…

• Hypersensitivity to Venlafaxine
• Myocardial infarction and/or unstable angina within 6 months of screening
• History of seizure disorder
• Other exclusions apply.

Where it is running

• Study site — Montgomery, Alabama, United States
• Study site — Peoria, Arizona, United States
• Study site — Upland, California, United States
• Study site — Colorado Springs, Colorado, United States
• Study site — Brooksville, Florida, United States
• Study site — Inverness, Florida, United States
• Study site — Miami, Florida, United States
• Study site — New Port Richey, Florida, United States
• Study site — Ocala, Florida, United States
• Study site — St. Petersburg, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Decatur, Georgia, United States
• Study site — Savannah, Georgia, United States
• Study site — Boise, Idaho, United States
• Study site — Idaho Falls, Idaho, United States
• Study site — Overland Park, Kansas, United States
• Study site — Louisville, Kentucky, United States
• Study site — Portland, Maine, United States
• Study site — Rockville, Maryland, United States
• Study site — Billings, Montana, United States
• Study site — Las Vegas, Nevada, United States
• Study site — Albuquerque, New Mexico, United States
• Study site — Winston-Salem, North Carolina, United States
• Study site — Bismarck, North Dakota, United States
• Study site — Fargo, North Dakota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.